Revolutions are often a long time in the making...

Motorola released the MicroTAC cellular phone in 1989... one of the first handheld mobile phones designed to be carried in a pocket and be accessible to average people.

By 1999, a decade after Motorola released the MicroTAC, roughly 500 million people around the world owned a cellphone, according to the United Nations' International Telecommunication Union. That figure doubled two years later. And by 2008, more than 4 billion people worldwide owned a mobile phone.

Today, worldwide, people are carting around 7.6 billion smartphones.

These numbers sound like relentless growth... The truth is, the mobile phone's development came in waves. Each generation resulted in a burst of new capabilities and drew in more and more users.

Remarkably, it wasn't a series of brilliant inventors who drove mobile-communication technology to where it is today... Rather, one company spent decades at the heart of the world's cellular network.

And at every turning point, it seemed as though this company's portfolio of patents was about to become obsolete... But this company never ceded ground to new competitors. Instead, it defied predictions of doom and produced key innovations for each new leg in the advancement of mobile technology.

And this mobile technology isn't just in our phones… It's in our watches, our appliances, and even our cars.

I'm not talking about iPhone maker Apple (AAPL). I'm talking about the electronics supplier Qualcomm (QCOM).

Qualcomm introduced CDMA technology in 1989 – the same year as the Motorola MicroTAC... Over time, that technology and other Qualcomm innovations became the backbone of the world's mobile networks.

Qualcomm's main business (52% of revenue for the most recent quarter) is producing computer chips for mobile devices. And its stock is up more than 30,000% since it went public in 1991.

But as most chipmaker stocks have surged this year, Qualcomm has begun falling behind. Mobile devices aren't part of the next big tech evolution... AI is.

Whatever your feelings are on AI, this technology demands a lot of computer chips. And it needs a lot more power than the Qualcomm chips in your phone.

Two of my colleagues just went on camera to discuss a new AI "super chip" that's 144 times faster than Qualcomm's.

They say this new chip could create the next generation of tech winners, including one California company whose stock could jump 1,000%.

Get the full story here – including a free stock pick from an AI expert who recommended Nvidia before it rose 35,000%.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

Stop Losses and Capital Gains  

Q: How do you rationalize taking stop losses that trigger a 15% capital gains tax on top of the drop in market value? Thank you. – S.M.

A: Thanks for your question, S.M.

As a reminder, a trailing stop follows the price of a stock up. If you buy Stock X at $10 and use a 20% trailing stop, your stop would start at $8. But if the price rose to $15, your stop would rise accordingly to $12. So if you stopped out of the stock at $12, you'd have a $2 gain.

Like you said, you'd owe a capital-gains tax on that $2. (How much depends on how long you held the stock and your tax bracket.)

But stop losses aren't meant to be a tax strategy. They're portfolio protection. They keep us from giving back all our gains on a stock that's going against us.

Would you rather give up some of your gains in taxes... or risk not even having any gains? For me, my priority is avoiding the loss.

If capital-gains tax is a primary concern, you can invest in a tax-advantaged account like an IRA. Then the gains stay in the account and only trigger a tax when you're ready to withdraw your cash.

You could also use a hard stop instead of a trailing stop. I do this with some of my recommendations. With a hard stop, you sell at a predetermined price... which could be either a fixed loss or breakeven. Then you're protected against a big loss while never worrying about a capital-gains tax. You could even take a capital loss that would offset any other gains.

But it means your big winners could dwindle into nothing, or even lose you money, before you finally bail out.

Whatever stop loss you use, the key is to stick with it. Getting attached to a falling stock is a losing strategy. Stop losses protect us from that mistake.

Q: A while back there was a discussion of the benefits of using a hot tub. Could you please allow me to access that email again to further understand the benefits of use of a hot tub. Thank you. – C.B.

A: Thanks for your readership, C.B. You can find that information – plus other heat-therapy questions we answered for readers – right here.

What We're Reading (and Watching)...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
October 23, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top